Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025

Difluorolactam compounds as EP4 receptor-selective agonists for use in the treatment of EP4-mediated diseases and conditions

US Patent 11884624 · Granted Jan 30, 2024

Assignee

Inventors

View full patent text on Google Patents →